Translational Development Acquisition Corp

Translational Development Acquisition Corp(TDAC)の株式分析

$10.840

+0.005 (+0.05%)終値時点

Loading chart…
High
10.870
Open
10.825
VWAP
10.84
Vol
5.23K
Mkt Cap
Low
10.825
Amount
56.76K
EV/EBITDA, TTM
0.00

Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.

AI analysis of Translational Development Acquisition Corp (TDAC)

hold

Translational Development Acquisition Corp (TDAC) is currently at a price of 10.84, with a recent 5-day change of -0.05% and a year-to-date change of +3.83%. The RSI is at 51.89, indicating a neutral momentum. While the merger with ProLogium could provide growth potential, the forward P/E ratio is 0, suggesting uncertainty in future earnings. The main risk is the negative net income reported in Q3 2024 at -61283.00 USD, which raises concerns about profitability.

バリュエーション指標

The current forward P/E ratio for Translational Development Acquisition Corp (TDAC) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
割高
0.00
割安
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
割高
0.00
割安
0.00

Forward P/S

Fair
5Y Average P/S
0.12
Current P/S
0.00
割高
1.22
割安
-0.98

Alphio AI Price Scenarios for TDAC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%TDAC

$9.29

シナリオ価格

B

Base

Base · 50%TDAC

$9.21

シナリオ価格

B

Bear

Bear · 25%TDAC

$8.24

シナリオ価格

TDAC FAQ — answered by Alphio AI

Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.

Translational Development Acquisition Corp (TDAC) is currently at a price of 10.84, with a recent 5-day change of -0.05% and a year-to-date change of +3.83%. The RSI is at 51.89, indicating a neutral momentum. While the merger with ProLogium could provide growth potential, the forward P/E ratio is 0, suggesting uncertainty in future earnings. The main risk is the negative net income reported in Q3 2024 at -61283.00 USD, which raises concerns about profitability.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める